172 related articles for article (PubMed ID: 21874265)
21. Characterization of a novel interaction between vasodilator-stimulated phosphoprotein and Abelson interactor 1 in human platelets: a concerted computational and experimental approach.
Dittrich M; Strassberger V; Fackler M; Tas P; Lewandrowski U; Sickmann A; Walter U; Dandekar T; Birschmann I
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):843-50. PubMed ID: 20110575
[TBL] [Abstract][Full Text] [Related]
22. [Significance of stathmin gene overexpression in osteosarcoma cells].
Zhang HZ; Gao P; Yan L; Lin F
Ai Zheng; 2004 May; 23(5):493-6. PubMed ID: 15142441
[TBL] [Abstract][Full Text] [Related]
23. Increased noise sensitivity and altered inner ear MENA distribution in VASP-/- mice.
Schick B; Praetorius M; Eigenthaler M; Jung V; Müller M; Walter U; Knipper M
Cell Tissue Res; 2004 Dec; 318(3):493-502. PubMed ID: 15578270
[TBL] [Abstract][Full Text] [Related]
24. Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.
Ali M; Heyob K; Jacob NK; Rogers LK
Mol Cancer Ther; 2016 Sep; 15(9):2220-31. PubMed ID: 27496138
[TBL] [Abstract][Full Text] [Related]
25. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium.
Schlegel N; Waschke J
J Cell Physiol; 2009 Aug; 220(2):357-66. PubMed ID: 19347869
[TBL] [Abstract][Full Text] [Related]
26. Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues.
Gambaryan S; Hauser W; Kobsar A; Glazova M; Walter U
Histochem Cell Biol; 2001 Dec; 116(6):535-43. PubMed ID: 11810195
[TBL] [Abstract][Full Text] [Related]
27. Differential phosphoproteome profiling reveals a functional role for VASP in Helicobacter pylori-induced cytoskeleton turnover in gastric epithelial cells.
Knauer O; Binai NA; Carra G; Beckhaus T; Hanschmann KM; Renné T; Backert S; Karas M; Wessler S
Cell Microbiol; 2008 Nov; 10(11):2285-96. PubMed ID: 18637808
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus type 1 entry into epithelial MDCKII cells: role of VASP activities.
Jaeger V; Hoppe S; Petermann P; Liebig T; Jansen MK; Renné T; Knebel-Mörsdorf D
J Gen Virol; 2010 Sep; 91(Pt 9):2152-7. PubMed ID: 20463151
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
[TBL] [Abstract][Full Text] [Related]
30. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of VASP by AMPK alters actin binding and occurs at a novel site.
Thomson DM; Ascione MP; Grange J; Nelson C; Hansen MD
Biochem Biophys Res Commun; 2011 Oct; 414(1):215-9. PubMed ID: 21945940
[TBL] [Abstract][Full Text] [Related]
32. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
[TBL] [Abstract][Full Text] [Related]
33. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
[TBL] [Abstract][Full Text] [Related]
34. Changes of vasodilator-stimulated phosphoprotein (VASP) and its phosphorylation in endothelial cells exposed to laminar flow.
Wei L; Muller S; Ouyang J; Stoltz JF; Wang X
Clin Hemorheol Microcirc; 2003; 28(2):113-20. PubMed ID: 12652017
[TBL] [Abstract][Full Text] [Related]
35. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
36. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of VASP in normal lung tissue and lung adenocarcinomas.
Dertsiz L; Ozbilim G; Kayisli Y; Gokhan GA; Demircan A; Kayisli UA
Thorax; 2005 Jul; 60(7):576-81. PubMed ID: 15994266
[TBL] [Abstract][Full Text] [Related]
38. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma.
Sueyoshi T; Jono H; Shinriki S; Ota K; Ota T; Tasaki M; Atsuyama E; Yakushiji T; Ueda M; Obayashi K; Mizuta H; Ando Y
Cancer Lett; 2012 Mar; 316(1):23-30. PubMed ID: 22099874
[TBL] [Abstract][Full Text] [Related]
40. Vasodilator-stimulated phosphoprotein: crucial for activation of Rac1 in endothelial barrier maintenance.
Schlegel N; Waschke J
Cardiovasc Res; 2010 Jul; 87(1):1-3. PubMed ID: 20308204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
